Swiss stocks - Factors to watch on March 13

Compagnie Financiere Tradition SA

13/03/2015 06:55

ZURICH, March 13 (Reuters) - The following are some of the 
main factors expected to affect Swiss stocks on Friday: 
       
    UBS  UBSG.VX  
    The Swiss bank said on Friday it had revised fourth-quarter 
net profit attributable to shareholders down by 105 million 
Swiss francs ($104.31 million), primarily because it increased 
legal reserves to 3.05 billion francs. 
    For more click on  UBSG.VX  
     
    COMPANY STATEMENTS  CPR-CH  
    * Novartis  NOVN.VX  said new results for Cosentyx in 
moderate-to-severe plaque psoriasis will be presented as late 
breaking research at the 73rd Annual Meeting of American Academy 
of Dermatology this month in San Francisco.  NOVN.VX  
    * Compagnie Financiere Tradition  CFT.S  said operating 
profit for 2014 increased by 31.1 percent in constant currencies 
to 41.2 million Swiss francs.  CFT.S  
    * Cytos Biotechnology  CYTN.S  said the superior composition 
authority of creditors of the canton of Zurich ruled that the 
sole resolution of the bond restructuring proposed in January to 
the bondholders and submitted to the court in February is 
approved.  CYTN.S  
    * Perrot Duval  PEDU.S  said it it recorded a loss of 1.3 
million Swiss francs in the first nine months of the 2014/2015 
financial year.  PEDU.S  
    * Cosmo Pharmaceuticals  COPN.S  announced the results of 
the preemptive offer to shareholders for the shares with respect 
to which cash exit rights were exercised in connection with the 
resolution on the relocation of the registered seat from Italy 
to Luxembourg. At completion of the offer period, 12 Cosmo 
shareholders elected to purchase 2,867 shares out of the total 
of 104,931 shares.  COPN.S  
 
    ECONOMY  M-CH  
     
 
 (Reporting by Zurich newsroom) 
 ((+41 58 306 7336)(zurich.newsroom@thomsonreuters.com))